HK1039449A1 - 治療多發性硬化的方法 - Google Patents

治療多發性硬化的方法

Info

Publication number
HK1039449A1
HK1039449A1 HK02100531.4A HK02100531A HK1039449A1 HK 1039449 A1 HK1039449 A1 HK 1039449A1 HK 02100531 A HK02100531 A HK 02100531A HK 1039449 A1 HK1039449 A1 HK 1039449A1
Authority
HK
Hong Kong
Prior art keywords
methods
multiple sclerosis
treating multiple
treating
sclerosis
Prior art date
Application number
HK02100531.4A
Other languages
English (en)
Inventor
Sai Latha Shankar L
G Tatton William
A Tatton Nadine
Original Assignee
Sai Latha Shankar L
G Tatton William
A Tatton Nadine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sai Latha Shankar L, G Tatton William, A Tatton Nadine filed Critical Sai Latha Shankar L
Publication of HK1039449A1 publication Critical patent/HK1039449A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02100531.4A 1998-10-09 2002-01-23 治療多發性硬化的方法 HK1039449A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10374298P 1998-10-09 1998-10-09
PCT/US1999/023482 WO2000021513A2 (en) 1998-10-09 1999-10-08 Methods for treating multiple sclerosis

Publications (1)

Publication Number Publication Date
HK1039449A1 true HK1039449A1 (zh) 2002-04-26

Family

ID=22296795

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100531.4A HK1039449A1 (zh) 1998-10-09 2002-01-23 治療多發性硬化的方法

Country Status (6)

Country Link
US (3) US6492427B2 (zh)
EP (1) EP1117391A2 (zh)
AU (1) AU1105800A (zh)
CA (1) CA2346773A1 (zh)
HK (1) HK1039449A1 (zh)
WO (1) WO2000021513A2 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156535A (en) * 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
US6133437A (en) * 1997-02-13 2000-10-17 Apoptogen, Inc. Modulation of IAPs for the treatment of proliferative diseases
US6492427B2 (en) * 1998-10-09 2002-12-10 L. Sai Latha Shankar Methods for treating multiple sclerosis
WO2001088834A2 (en) * 2000-05-17 2001-11-22 New York University Method and system for data classification in the presence of a temporal non-stationarity
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
WO2005000203A2 (en) * 2001-10-31 2005-01-06 Sention, Inc. Methods for treating cognitive impairment and improving cognition
BR0308923A (pt) * 2002-03-27 2005-01-04 Aegera Therapeutics Inc OligÈmeros de nucleobase de iap anti-sentido e empregos destes
CN103540568A (zh) * 2002-04-26 2014-01-29 米迪缪尼有限公司 制备流感病毒的多质粒***
US8012944B2 (en) * 2003-10-30 2011-09-06 Pharmascience Inc. Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent
CN101351544B (zh) * 2005-08-26 2013-06-12 罗切斯特大学 胶质限制性前体衍生的星形胶质细胞移植以促进轴突生长
IS2385B (is) * 2006-02-10 2008-07-15 Actavis Group Hf. Klópidógrel bísúlfat lyfjasamsetningar
CN101358609A (zh) * 2007-08-03 2009-02-04 富准精密工业(深圳)有限公司 风扇转子
WO2010054307A1 (en) * 2008-11-07 2010-05-14 The Cleveland Clinic Foundation Compounds and methods of promoting oligodendrocyte precursor differentiation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5444095A (en) 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US6348208B1 (en) * 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
CN100360123C (zh) 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
US5679715A (en) * 1995-06-07 1997-10-21 Harris; Richard Y. Method for treating multiple sclerosis
GB9600660D0 (en) 1996-01-12 1996-03-13 Ciba Geigy Ag Protein
US6492427B2 (en) * 1998-10-09 2002-12-10 L. Sai Latha Shankar Methods for treating multiple sclerosis

Also Published As

Publication number Publication date
WO2000021513A3 (en) 2000-08-24
US6492427B2 (en) 2002-12-10
WO2000021513A9 (en) 2000-10-12
US20020022661A1 (en) 2002-02-21
US20050004229A1 (en) 2005-01-06
WO2000021513A2 (en) 2000-04-20
US20030078295A1 (en) 2003-04-24
EP1117391A2 (en) 2001-07-25
AU1105800A (en) 2000-05-01
CA2346773A1 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
IL142248A0 (en) Methods for treating sepsis
HK1039449A1 (zh) 治療多發性硬化的方法
GB9809414D0 (en) Method
GB0226147D0 (en) Treatment for multiple sclerosis
GB9809776D0 (en) Method
GB9814055D0 (en) Method
GB9819764D0 (en) Method
EP1043994A4 (en) METHOD OF TREATING MULTIPLE SCLEROSIS
GB9819769D0 (en) Method
GB9802475D0 (en) Method
GB9817266D0 (en) Method
GB9824321D0 (en) Method
GB9821225D0 (en) Method
GB9820185D0 (en) Method
GB9809780D0 (en) Method
GB9821038D0 (en) Method
GB9809782D0 (en) Method
GB9804355D0 (en) Method
GB9823963D0 (en) Method
GB9825374D0 (en) Method
AU1167P (en) Treat xTriticosecale
SG77621A1 (en) Distribution method
GB9602269D0 (en) Novel compounds and methods for treating multiple sclerosis
GB9813089D0 (en) Method
GB9811185D0 (en) Method